Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
975 Sereno Dr
Vallejo, CA 94589Phone+1 707-651-1000
Education & Training
Shanghai Medical UniversityClass of 1991
National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
CA State Medical License 2008 - 2026
VA State Medical License 2005 - 2010- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 31 citationsA Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell CarcinomaHui Huang, Michael E. Menefee, Maureen Edgerly, Sen Zhuang, Herb Kotz
Clinical Cancer Research. 2010-03-01 - 50 citationsAdjuvant Mitotane for Adrenocortical Cancer—A Recurring ControversyHui Huang, Tito Fojo
The Journal of Clinical Endocrinology and Metabolism. 2008-10-01 - 148 citationsTreatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.Hui Huang, Jame Abraham, Elizabeth Hung, Steven D. Averbuch, Maria J. Merino
Cancer. 2008-10-15
Press Mentions
Takeda Weitet Onkologieforschung Aus Und Stellt Engagement Für Patientengemeinschaft Auf 15May 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
